Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
City approves participation in national opioid settlements, estimates recoveries over 15 years
Summary
Grand Rapids approved participation agreements for national opioid litigation settlements, including an estimated recovery of about $824,818.39 from Purdue Pharma and smaller settlements from other manufacturers, with uses restricted to prevention/treatment/abatement.
The City Commission on Aug. 26 adopted resolutions authorizing participation in partial settlements related to national prescription opioid litigation.
Commissioner Robbins summarized two items: a proposed national settlement covering several manufacturers with an estimated recovery of approximately $128,877.87 distributed over 15 years, and a separate settlement with Purdue Pharma LP yielding an estimated $824,818.39 over 15 years. Commissioners voted to adopt participation agreements and the associated state/local allocation arrangements.
The commission noted that settlement proceeds are restricted under the national agreements; permissible uses generally include treatment, prevention and abatement of opioid‑related harms.
Why it matters: The settlements provide funds to address local opioid treatment and mitigation efforts but are distributed over many years and come with constraints on allowable uses.
What’s next: Staff and legal counsel will finalize participation paperwork and coordinate with state/local allocation processes to use proceeds for authorized programs.
